We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.2B
AUM Growth
+$642M
Cap. Flow
-$66.7M
Cap. Flow %
-0.59%
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97

Sector Composition

Rank Sector Weight
1 Energy 63.96%
2 Technology 5.43%
3 Healthcare 4.22%
4 Consumer Discretionary 3.76%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMTX icon
1026
Aemetis
AMTX
$119M
-194,078
Closed -$1.19M
ARCT icon
1027
Arcturus Therapeutics
ARCT
$157M
-14,481
Closed -$215K
ASND icon
1028
Ascendis Pharma A/S
ASND
$16.7B
-30,416
Closed -$3.14M
ASR icon
1029
Grupo Aeroportuario del Sureste
ASR
$8.03B
-2,584
Closed -$507K
AUTL
1030
Autolus Therapeutics
AUTL
$386M
-49,657
Closed -$106K
AVB icon
1031
AvalonBay Communities
AVB
$27.1B
-2,433
Closed -$448K
BCYC
1032
Bicycle Therapeutics
BCYC
$270M
-16,186
Closed -$376K
CAG icon
1033
Conagra Brands
CAG
$7.07B
-717,827
Closed -$23.4M
CAH icon
1034
Cardinal Health
CAH
$53.4B
-353,008
Closed -$23.5M
CCCC icon
1035
C4 Therapeutics
CCCC
$376M
-26,696
Closed -$234K
CGEM icon
1036
Cullinan Oncology
CGEM
$1.05B
-24,941
Closed -$320K
CNTA
1037
DELISTED
Centessa Pharmaceuticals
CNTA
-51,503
Closed -$207K
CRSP icon
1038
CRISPR Therapeutics
CRSP
$4.58B
-42,581
Closed -$2.78M
DAL icon
1039
Delta Air Lines
DAL
$55.9B
-7,680
Closed -$216K
DEA
1040
Easterly Government Properties
DEA
$1.18B
-11,418
Closed -$450K
AXIA
1041
AXIA Energia
AXIA
$22.6B
-81,147
Closed -$516K
EDIT icon
1042
Editas Medicine
EDIT
$399M
-37,504
Closed -$459K
ENIC icon
1043
Enel Chile
ENIC
$5.96B
-313,479
Closed -$433K
EPIX
1044
DELISTED
ESSA Pharma
EPIX
-24,052
Closed -$44K
EPRT icon
1045
Essential Properties Realty Trust
EPRT
$6.99B
-23,196
Closed -$451K
EQR icon
1046
Equity Residential
EQR
$25.4B
-6,758
Closed -$454K
ERAS icon
1047
Erasca
ERAS
$6.63B
-66,663
Closed -$520K
FATE icon
1048
Fate Therapeutics
FATE
$281M
-52,950
Closed -$1.19M
FDMT icon
1049
4D Molecular Therapeutics
FDMT
$526M
-17,663
Closed -$142K
FE icon
1050
FirstEnergy
FE
$28.9B
-594,355
Closed -$22M

Similar funds

ALPS Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ALPS Advisors held 1,116 positions worth $11.2B, up 6.1% from $10.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q4 2022 filing shows 76 new, 314 increased, 582 reduced and 97 closed positions. Its largest new stake was Albemarle: 124,308 shares worth $27M. The largest sale was Shell Midstream Partners, L.P., an estimated $280M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2022 buy was Albemarle: 124,308 shares worth $27M.
  • ALPS Advisors added most to Crestwood Equity Partners LP in Q4 2022, an estimated $62.5M increase.
  • ALPS Advisors's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $28.2M.
  • ALPS Advisors fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $280M.
  • ALPS Advisors's ten largest holdings make up 52% of its $11.2B portfolio in Q4 2022.
  • ALPS Advisors opened 76 new positions and closed 97 in Q4 2022.
  • ALPS Advisors's portfolio value rose 6.1% quarter-over-quarter to $11.2B.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.